Literature DB >> 14633129

Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy.

Anita M Saran1, Huaping Yuan, Emiko Takeuchi, Margaret McLaughlin, David J Salant.   

Abstract

BACKGROUND: The onset of proteinuria in passive Heymann nephritis, (PHN), a rat model of human membranous nephropathy (MN), is complement-dependent and is associated with altered podocyte slit diaphragm integrity and dissociation of nephrin from the actin cytoskeleton. These studies examined if complement is responsible for these podocyte changes.
METHODS: PHN was induced with sheep anti-Fx1A. Controls were injected with normal sheep globulin. A third group was injected with anti-Fx1A and depleted of complement with cobra venom factor. Four days later, proteinuria was measured, slit diaphragm integrity was examined by electron microscopy, nephrin distribution was studied by immunofluorescence, and the glomerular content of nephrin and its association with actin were assessed by sequential extraction of isolated glomeruli and Western blotting.
RESULTS: Four days after immunization, seven out of eight PHN rats were proteinuric, whereas none of the complement depleted group had proteinuria despite similar levels of antibody deposition. Complement depletion preserved slit diaphragm morphology. Immunofluorescence microscopy with an antibody to the extracellular domain of nephrin showed a normal staining pattern in the rats depleted of complement and a shift to a more dispersed and clustered pattern in the PHN group. Western blot analysis of the glomerular extracts showed a significant reduction in the total amount of nephrin and in the fraction of actin-associated nephrin in the PHN group, whereas the amounts in the complement-depleted rats were similar to normal controls.
CONCLUSION: The onset of proteinuria in the PHN model of MN is coincident with complement-dependent alterations in the association of nephrin with the actin cytoskeleton and loss of podocyte slit diaphragm integrity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14633129     DOI: 10.1046/j.1523-1755.2003.00305.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  17 in total

Review 1.  Experimental membranous nephropathy redux.

Authors:  Andrey V Cybulsky; Richard J Quigg; David J Salant
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

2.  Experimental Models of Membranous Nephropathy.

Authors:  J Ashley Jefferson; Jeffrey W Pippin; Stuart J Shankland
Journal:  Drug Discov Today Dis Models       Date:  2010

3.  Na+/H+ exchanger-1 reduces podocyte injury caused by endoplasmic reticulum stress via autophagy activation.

Authors:  Zhe Feng; Li Tang; Lingling Wu; Shaoyuan Cui; Quan Hong; Guangyan Cai; Di Wu; Bo Fu; Ribao Wei; Xiangmei Chen
Journal:  Lab Invest       Date:  2014-02-24       Impact factor: 5.662

Review 4.  Molecules Great and Small: The Complement System.

Authors:  Douglas R Mathern; Peter S Heeger
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 8.237

5.  Possible role of autoantibodies against nephrin in an experimental model of chronic graft-versus-host disease.

Authors:  K Nagahama; K Maru; S Kanzaki; H L Chai; T Nakai; S Miura; A Yamaguchi; S Yamanaka; Y Nagashima; I Aoki
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

6.  Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy.

Authors:  George Haddad; Johan M Lorenzen; Hong Ma; Noortje de Haan; Harald Seeger; Christelle Zaghrini; Simone Brandt; Malte Kölling; Urs Wegmann; Bence Kiss; Gábor Pál; Péter Gál; Rudolf P Wüthrich; Manfred Wuhrer; Laurence H Beck; David J Salant; Gérard Lambeau; Andreas D Kistler
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

7.  De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.

Authors:  Takamoto Ohse; Michael R Vaughan; Jeffrey B Kopp; Ronald D Krofft; Caroline B Marshall; Alice M Chang; Kelly L Hudkins; Charles E Alpers; Jeffrey W Pippin; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-09

Review 8.  An update on the pathomechanisms and future therapies of Alport syndrome.

Authors:  Damien Noone; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2012-08-18       Impact factor: 3.714

Review 9.  Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men.

Authors:  P Ronco; H Debiec
Journal:  Semin Immunopathol       Date:  2007-09-26       Impact factor: 9.623

10.  Microarray and bioinformatics analysis of gene expression in experimental membranous nephropathy.

Authors:  Peter V Hauser; Paul Perco; Irmgard Mühlberger; Jeffrey Pippin; Mary Blonski; Bernd Mayer; Charles E Alpers; Rainer Oberbauer; Stuart J Shankland
Journal:  Nephron Exp Nephrol       Date:  2009-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.